Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120884492 | 12088449 | 2 | F | 20150616 | 20160218 | 20160727 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK017832 | GLENMARK | SHUSTER M., SHETH V.. NASAL BRIDGE NOCARDIA VIA DIRECT INOCULATION IN A NONIMMUNOSUPPRESSED PATIENT. 73RD ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2015;72 (5 SUPPL. 1):PP AB128 | 42.00 | YR | F | Y | 0.00000 | 20160727 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120884492 | 12088449 | 1 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK, BID | U | 0 | BID | |||||||||
| 120884492 | 12088449 | 2 | PS | MUPIROCIN. | MUPIROCIN | 1 | UNK | U | 90480 | OINTMENT | |||||||||
| 120884492 | 12088449 | 3 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | UNK, BID | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120884492 | 12088449 | 1 | Nocardiosis |
| 120884492 | 12088449 | 2 | Nocardiosis |
| 120884492 | 12088449 | 3 | Nocardiosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120884492 | 12088449 | Off label use | |
| 120884492 | 12088449 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |